Epilepsy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Epilepsy is a chronic brain disorder characterized by the occurrence of seizures, which arise from erroneous signals sent by specific neural cell clusters in the brain. Neurons transmit electrical and chemical impulses to generate human thoughts, emotions, and actions, affecting other neurons, organs, and muscles. There are four main types of epilepsy:
1. Temporal lobe epilepsy (TLE)
2. Frontal lobe epilepsy
3. Neocortical epilepsy
4. Absence epilepsy
Identifying the precise cause of epilepsy is crucial for devising an effective treatment strategy. Various tests are conducted to determine whether an individual has epilepsy and, if so, the type of seizures they experience. Typically, epilepsy is diagnosed when a person experiences two or more unprovoked seizures separated by at least 24 hours. Surgery is usually considered only after a patient has unsuccessfully tried at least two drug regimens to control seizures or when a brain lesion is identified as the probable cause of the seizures.
• Approximately 1.1% of adults in the United States, equivalent to around 2,865,000 individuals, reported active epilepsy, while 0.6% (approximately 1,637,000 adults) reported inactive epilepsy.

Thelansis’s “Epilepsy Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Epilepsy treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Epilepsy across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Epilepsy Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Epilepsy – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033